Literature DB >> 29409149

Absolute Configuration of Pharmaceutical Research Compounds Determined by X-ray Powder Diffraction.

Carina Schlesinger1, Lukas Tapmeyer1, Silke D Gumbert1, Dragica Prill1, Michael Bolte1, Martin U Schmidt1, Christoph Saal2.   

Abstract

The absolute configuration of active pharmaceutical ingredients (APIs) was determined by generating salts of the active pharmaceutical ingredient (API) with counterions of known chirality, and determining the crystal structures by X-ray powder diffraction. This approach avoids the (often tedious) growth of single crystals, and is successful with very limited quantities of material (less than 1 mg). The feasibility of the method is demonstrated on five examples, and its limitations are discussed as well.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  Rietveld refinement; X-ray powder diffraction; configuration determination; pharmaceutical compounds; structure determination

Mesh:

Substances:

Year:  2018        PMID: 29409149     DOI: 10.1002/anie.201713168

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  3 in total

1.  Insight into the Structure and Properties of Novel Imidazole-Based Salts of Salicylic Acid.

Authors:  Inês C B Martins; Dominik Al-Sabbagh; Klas Meyer; Michael Maiwald; Gudrun Scholz; Franziska Emmerling
Journal:  Molecules       Date:  2019-11-15       Impact factor: 4.411

2.  Absolute configuration determination of pharmaceutical crystalline powders by MicroED via chiral salt formation.

Authors:  Bo Wang; Jessica F Bruhn; Asmerom Weldeab; Timothy S Wilson; Philip T McGilvray; Michael Mashore; Qiong Song; Giovanna Scapin; Yiqing Lin
Journal:  Chem Commun (Camb)       Date:  2022-04-12       Impact factor: 6.222

Review 3.  The Lisbon Supramolecular Green Story: Mechanochemistry towards New Forms of Pharmaceuticals.

Authors:  João Luís Ferreira da Silva; M Fátima Minas da Piedade; Vânia André; Sofia Domingos; Inês C B Martins; M Teresa Duarte
Journal:  Molecules       Date:  2020-06-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.